Panacea Biotec Ltd
Panacea Biotec Ltd (PANACEABIO) last traded at ₹406, a market capitalisation of ₹2,487 crore. Over the past 52 weeks the stock has ranged between ₹292 and ₹648. Panacea Biotec Ltd last reported results for the quarter ended Jun 2026, with sales of ₹200 crore and net profit of ₹2.2 crore. Panacea Biotec Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Panacea Biotec Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Panacea Biotec Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹200 cr, up 19.7% from ₹167 cr a year earlier. Net profit was ₹2.2 cr, down 44.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 147 | 163 | 133 | 167 | 141 | 165 | 167 | 200 |
| Expenses | 140 | 156 | 159 | 168 | 159 | 153 | 164 | 194 |
| Operating profit | 7 | 7.96 | -26.88 | -1.18 | -17.79 | 11.74 | 2.57 | 5.67 |
| OPM % | 4.75% | 4.87% | -20.28% | -0.71% | -12.61% | 7.11% | 1.54% | 2.84% |
| Other income | 7.42 | 6.39 | 36.3 | 16.99 | 9.1 | 5.05 | 5.26 | 6.98 |
| Interest | 0.98 | 0.99 | 1.04 | 0.86 | 2.14 | 1.85 | 1.2 | 1.18 |
| Depreciation | 8.68 | 8.98 | 8.42 | 8.39 | 8.34 | 8.45 | 7.88 | 7.9 |
| Profit before tax | 4.76 | 4.38 | -0.04 | 6.56 | -19.17 | 6.49 | -1.25 | 3.57 |
| Tax % | 1.05% | -1.37% | 4,875.00% | 39.63% | -26.92% | 40.06% | -20.00% | 38.38% |
| Net profit | 4.71 | 4.44 | -1.99 | 3.96 | -14.01 | 3.89 | -1 | 2.2 |
| EPS (₹) | 0.78 | 0.74 | -0.31 | 0.66 | -2.27 | 0.65 | 0.08 | 0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Panacea Biotec Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 625 | 661 | 460 | 559 | 559 | 640 | 673 |
| Operating profit | 77 | -13 | -98 | -20 | -25 | -5 | 2 |
| OPM % | 12% | -2.0% | -21% | -3.5% | -4.4% | -0.7% | 0.3% |
| Net profit | -148 | 1,078 | -34 | -2 | -9 | -7 | -9 |
| EPS (₹) | -24.09 | 175.91 | -5.42 | -0.19 | -1.37 | -0.88 | -1.16 |
TTM is the trailing twelve months to the most recent quarter.
Panacea Biotec Ltd growth and returns
- 10 Years
- 0%
- 5 Years
- 0%
- 3 Years
- 12%
- TTM
- 10%
- 10 Years
- 5%
- 5 Years
- 13%
- 3 Years
- 21%
- TTM
- 43%
- 10 Years
- 15%
- 5 Years
- 6%
- 3 Years
- 43%
- 1 Year
- 1%
- 10 Years
- %
- 5 Years
- -10%
- 3 Years
- -3%
- Last Year
- -2%
Panacea Biotec Ltd shareholding pattern
Promoters held 72.48% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.31% and DIIs 2.25%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.87% | 72.49% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% |
| FIIs | 0.37% | 0.38% | 1.16% | 0.79% | 1.06% | 1.36% | 1.60% | 2.31% |
| DIIs | 1.16% | 1.16% | 1.49% | 1.52% | 1.80% | 1.85% | 1.96% | 2.25% |
| Public | 25.60% | 25.96% | 24.86% | 25.20% | 24.65% | 24.31% | 23.96% | 22.96% |
| No. of shareholders | 39,982 | 35,446 | 33,593 | 34,256 | 33,593 | 34,597 | 32,620 | 33,532 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Panacea Biotec Ltd’s AGM?
Panacea Biotec Ltd’s annual general meeting is scheduled for 29 Sept 2026.
- AGM42nd Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Panacea Biotec Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Panacea Biotec Limited has issued a public notice regarding its 42nd Annual General…
Read the full analysis - Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatemedium impact
Cruxal's analysis: Panacea Biotec Limited has released its unaudited standalone and consolidated financial…
Read the full analysis - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026Board Meetinghigh impact
Cruxal's analysis: Panacea Biotec Limited has reported a return to profitability for the quarter ended June…
Read the full analysis - Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Panacea Biotec has published a newspaper notice informing shareholders about the opening…
Read the full analysis - Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Standalone and Consolidated ....Board Meetinglow impact
Cruxal's analysis: Panacea Biotec Limited has formally notified the stock exchanges that its Board of…
Read the full analysis - Details Of Shares Dematerialized During July 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Panacea Biotec Ltd has submitted its routine compliance filing under Regulation 74(5) of…
Read the full analysis - We are delighted to inform you that the Company has received Letter of Award for supply of bivalent Oral Polio Vaccine (bOPV) to UNICEF in 10 and 20 dose presentation worth ~US$8.205 million ....Company Updatemedium impact
Cruxal's analysis: Panacea Biotec Limited has received a Letter of Award from UNICEF for the supply of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Panacea Biotec Ltd
Cruxal reads every Panacea Biotec Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.